Somatostatin and its receptor family

Frontiers in Neuroendocrinology

Volumn 20, Issue 3, 1999, Pages 157-198

  Patel, Yogesh C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cell proliferation; Expression; Receptors; Secretion; Signal transduction; Somatostatin

Indexed keywords

SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

APOPTOSIS; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GROWTH HORMONE RELEASE; HORMONE RESPONSE; IMMUNOREACTIVITY; LIGAND BINDING; MOLECULAR CLONING; NEUROENDOCRINOLOGY; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SOMATOSTATIN RELEASE;

EID: 0032780823     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1999.0183     Document Type: Article

References (233)

1. Aguila M C. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc Natl Acad Sci USA. 91:1994;782-786.
2. Aguila M C, Dees W L, Haensly W E, McCann S M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci USA. 88:1991;11485-11489.
3. Aguila M C, Rodriguez A M, Aguila-Mansilla H N, Lee W T. Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture. Endocrinology. 137:1996;1585-1590.
4. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5 in transfected COS-7 cells. FEBS Lett. 348:1994;192-196.
5. Amherdt M, Patel Y C, Orci L. Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest. 80:1987;1455-1458.
6. Amherdt M, Patel Y C, Orci L. Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells. J Clin Invest. 84:1989;412-417.
7. Baldwin J M. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol. 6:1994;180-190.
8. Barber D L, McGuire M E, Ganz M B. Beta-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP. J Biol Chem. 264:1989;21038-21042.
9. Bass R T, Buckwalter B L, Patel B P, Pausch M H, Price L A, Strnad J, Hadcock J R. Identification and characterization of novel somatostatin antagonists. Mol Pharmacol. 50:1996;709-715.
10. Bauer W, Briner U, Doepfner W, Halber R, Huguenin R, Marbach P, Petcher T J, Pless J. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31:1982;1133-1140.
11. Baumeister H, Kreuzer O J, Roosterman D, Schafer J, Meyerhof W. Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5. J Neuroendocrinol. 10:1998;283-290.
12. Berelowitz M, Firestone S, Frohman L A. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology. 109:1981;714-719.
13. Berelowitz M, Szabo M, Frohman L A, Firestone S, Chu L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1981;1279-1281.
14. Bito H, Mori M, Sakanaka C, Takano T, Honda Z, Gotoh Y, Nishida E, Shimizu T. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade. J Biol Chem. 269:1994;12722-12730.
15. Blum A M, Metwali A, Matthew R C, Cook G, Elliott D, Weinstock J V. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-γ secretion. J Immunol. 149:1992;3621-3626.
16. Bousquet C, Delesque N, Lopez F, Saint-Laurent N, Esteve J P, Bedecs K, Buscail L, Vaysse N, Susini C. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem. 273:1998;7099-7106.
17. Brazeau P, Vale W W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 179:1973;77-79.
18. Breder C D, Yamada Y Y, Yasuda K, Seino S, Saper C B, Bell G I. Differential expression of somatostatin receptor subtypes in brain. J Neurosci. 12:1992;3920-3934.
19. Brevini T AL, Bianchi R, Motta M. Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: Possible mechanism of action. J Clin Endocrinol Metab. 77:1993;626-631.
20. Brown P J, Lee A B, Norman M G, Presky D H, Schonbrunn A. Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog. J Biol Chem. 265:1990;17995-18004.
21. 3 cells. Biochem Biophys Res Commun. 202:1994;1738-1743.
22. Bruno J F, Xu Y, Song J, Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci USA. 89:1992;11151-11155.
23. Bruno J F, Xu Y, Song J, Berelowitz M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology. 133:1993;2561-2567.
24. Bruno J F, Xu Y, Song J, Berelowitz M. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Endocrinology. 135:1994;1787-1792.
25. Bruns C, Raulf F, Hoyer D, Schloos J, Lubbert H, Weckbecker G. Binding properties of somatostatin receptor subtypes. Metabolism. 45:1996;17-20.
26. Buscail L, Delesque N, Esteve J-P, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell G I, Liebow C, Schally A V, Vaysse N, Susini C. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA. 91:1994;2315-2319.
27. Buscail L, Esteve J-P, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll A M, Bell G I, Schally A V, Vaysse N, Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA. 92:1995;1580-1584.
28. Candi E, Melino G, de Lauranzi V, Piamente M, Guerrei P, Spinedi A, Knight R A. Tamoxifen and somatostatin affect tumors by inducing apoptosis. Cancer Lett. 96:1995;141-145.
29. Caron P, Buscail L, Beckers A, Esteve J-P, Igout A, Hennen G, Susini C. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentrations during pregnancy. J Clin Endocr Metab. 82:1997;3771-3776.
30. Cattaneo M G, Amoroso D, Gussoni G, Sanguini A M, Vincenti L M. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines. FEBS Lett. 397:1996;164-168.
31. Chen L, Fitzpatrick D, Vandlen R L, Tashjian A H. Both overlapping and distinct signalling pathways for somatostatin receptor subtype SSTR1 and SSTR2 in pituitary cells. J Biol Chem. 272:1997;18666-18672.
32. 3 rat pituitary tumor cell proliferation via a transient Go/Gi cell cycle block. Endocrinology. 136:1995;4174-4181.
33. Cordelier P, Esteve J-P, Bousquet C. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci USA. 94:1997;9343-9348.
34. Corness J D, Demchyshyn L L, Seeman P, Van Tol H HM, Srikant C B, Kent G, Patel Y C, Niznik H B. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett. 321:1993;279-284.
35. Day R, Dong W, Panetta R, Kraicer J, Greenwood M T, Patel Y C. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology. 136:1995;5232-5235.
36. De Lecea L, Criado J R, Prospero-Garcia O, Gautvik K M, Schweitzer P, Danielson P E, Dunlop C LM, Siggins G R, Henriksen S J, Sutcliffe J G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature. 381:1996;242-245.
37. Demchyshyn L L, Srikant C B, Sunahara R K, Kent G, Seeman P, Van Tol H HM, Panetta R, Patel Y C, Niznik H B. Cloning and expression of a human somatostatin-14 selective receptor variant (SSTR4) located on chromosome 20. Mol Pharmacol. 43:1993;894-901.
38. + channels in insulinoma cells: Activation by somatostatin and protein kinase C and the role of cAMP. Proc Natl Acad Sci USA. 86:1989;2971-2975.
39. Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J. Effect of 17 beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology. 139:1998;2272-2277.
40. Dohlman H G, Thorner J, Caron M G, Lefkowitz R J. Model systems for the study of seven transmembrane segment receptors. J Biol Chem. 268:1991;337-341.
41. Dournaud P, Boudin H, Schonbrunn A, Tannenbaum G S, Beaudet A. Interrelationships between somatostatin SST2A receptors and somatostatin-containing axons in rat brain. Evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci. 18:1998;1056-1071.
42. Dournaud P, Gu Y Z, Schonbrunn A, Mazella J, Tannenbaum G S, Beaudet A. Localization of the somatostatin receptor SST2A in rat brain using a specific antipeptide antibody. J Neurosci. 16:1996;4468-4478.
43. Dubois M P. Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci USA. 72:1975;1340-1343.
44. Elliott D E, Blum A M, Li J, Metwaki A, Weinstock J V. Preprosomatostatin messenger RNA is expressed by inflammatory cells and induced by inflammatory mediators and cytokines. J Immunol. 160:1998;3997-4003.
45. Elliott D E, Metwali A, Blum A M, Sandor M, Lynch R, Weinstock J V. T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA. J Immunol. 153:1994;1180-1186.
46. Epelbaum J, Dournaud P, Fodor M, Viollet C. The neurobiology of somatostatin. Crit Rev Neurobiol. 8:1994;25-44.
47. Evans C J, Keith D E Jr, Morrison H, Magendzo K, Edwards R H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
48. Ferone D, Van Hagen P M, Van Koetsveld P M, Zuijderwijk J, Mooy D M, Lichtenauer-Kaligis E GR, Colao A, Bogers A JJC, Lombardi G, Lamberts S WJ, Hofland L J. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells. Endocrinology. 140:1999;373-380.
49. Finley J CW, Maderdrut J L, Roger L J, Petrusz P. The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system. Neurosci. 6:1981;2173-2192.
50. Fitz-Patrick V D, Vandlen R L. Six agonist selectivity determinants in somatostatin receptor subtypes I and II. J Biol Chem. 269:1994;24621-24626.
51. Flanagan C A, Becker I I, Davidson J S, Wakefield I K, Zhou W, Sealfon S C, Miller R P. Glutamate 301 of the mouse gonadotrophin releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotrophin releasing hormone. J Biol Chem. 269:1994;22636-22641.
52. Florio T, Rim C, Hershberger R E, Loda M, Stork P J. The somataostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol. 8:1994;1289-1297.
53. Florio T, Scarziello A, Fattore M, Dalto V, Salzano S, Rossi G, Berlingieri M T, Fusco A, Schettini G. Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity-impairment of the somatostatinergic effects by stable expression of EIA viral oncogene. J Biol Chem. 271:1996;6129-6136.
54. Florio T, Yao H, Carey K D, Dillon T J, Stork P JS. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Mol Endocrinol. 13:1999;24-37.
55. Fujii Y, Gonoi T, Yamada Y, Chihara K, Inagaki N, Seino S. Somatostatin receptor subtype SSTR2 mediates the inhibition of high voltage activated calcium channels by somatostatin and its analogue SMS201-995. FEBS Lett. 355:1994;117-120.
56. Fukusumi S, Kitada C, Takekawa S, Kizawa H, Sakomoto J, Miyamoto M, Hinuma S, Kitano K, Fujino M. Identification and characterization of a novel human corticostatin like peptide. Biochem Biophys Res Commun. 232:1997;157-163.
57. Fuller P, Verity K. Somatostatin gene expression in the thymus gland. J Immunol. 143:1989;1015-1017.
58. Gether U, Johansen T E, Snider R M, Lowe J A, Edmons-Alt X, Yokota Y, Nakamishi S, Schwartz T W. Binding epitopes for peptide and nonpeptide ligands on the NK1 (substance P) receptor. Regul Pep. 46:1993;49-58.
59. Grant M B, Wargovich T J, Ellis E A, Caballero S, Mansour M, Pepine C J. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis. Circulation. 89:1994;1511-1517.
60. Greenwood M T, Hukovic N, Kumar U, Panetta R, Hjorth S A, Srikant C B, Patel Y C. Ligand binding pocket of the human somatostatin receptor 5 (hsstr5): Mutational analysis of the extracellular domains. Mol Pharmacol. 52:1997;807-814.
61. Greenwood M T, Panetta R, Robertson L A, Liu J-L, Patel Y C. Sequence analysis of the 5′-flanking promoter region of the human somatostatin receptor 5. Biochem Biophys Res Commun. 205:1994;1883-1890.
62. Greenwood M T, Robertson L A, Patel Y C. Cloning of the gene encoding the human somatostatin receptor 2: Sequence analysis of the 5′ flanking promoter region. Gene. 159:1995;291-292.
63. Gu Y-Z, Schonbrunn A. Coupling specificity between somatostatin receptor sst2A and G proteins: Isolation of the receptor-G protein complex with a receptor antibody. Mol Endocrinol. 11:1997;527-537.
64. Hauser F, Meyerhof W, Wulfsen I, Schonrock C, Richter D. Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene. FEBS Lett. 345:1994;225-228.
65. Hayry P, Raisanen A, Ustinov J, Mennander A, Paavonen T. Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J. 7:1993;1055-1060.
66. Helboe L, Moller M, Novregaard L, Schiodt M, Stidsen C E. Development of selective antibodies against the human somatostatin receptor subtypes SST1-SST5. Mol Brain Res. 49:1997;82-88.
67. 1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus. J Neurosci. 18:1998;4938-4945.
68. 1) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience. 85:1998;1263-1284.
69. Hierowski M T, Liebow C, du Sapin K, Schally A V. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer Mia PaCA-2 cell line. FEBS Lett. 179:1985;252-256.
70. 2A somatostatin receptor. J Biol Chem. 27:1997;13869-13876.
71. Hjorth S A, Schambye H T, Greenlee W J, Schwartz T W. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem. 269:1994;30953-30959.
72. Hobart P, Crawford R, Shen L-P, Pictet R, Rutter W J. Cloning and sequencing analysis of cDNAs encoding two distinct somatostatin precursors found in endocrine pancreas of anglerfish. Nature. 288:1980;137-141.
73. 3] octreotide by somatostatin receptor-positive cells in vitro and in vivo: Implications for somatostatin receptor-targeted radioguided surgery. Proc Assoc Amer Phys. 111:1999;63-69.
74. 3] octreotide by mouse and human pituitary tumor cells: Increase by unlabelled octreotide. Endocrinology. 136:1995;3698-3706.
75. 1 cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol. 80:1975;5-41.
76. Hou C, Gilbert R L, Barber D L. Subtype-specific signalling mechanisms of somatostatin receptors SSTR1 and SSTR2. J Biol Chem. 269:1994;10357-10362.
77. Hoyer D, Lubbert H, Bruns C. Molecular pharmacology of somatostatin receptors. Arch Pharmacol. 350:1994;441-453.
78. Hoyer D, Bell G I, Berelowitz M, Epelbaum J, Feniuk W, Humphrey P PA, O'Carroll A M, Patel Y C, Schonbrunn A, Taylor J E, Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 16:1995;86-88.
79. Hukovic, N, Kumar, U, Sasi, R, Khare, S, Rocheville, M, Patel, Y, C. Agonist-dependent upregulation of human somatostatin receptor type 1 (hSSTR1) requires molecular signals in the cytoplasmic C-tail. Program Annual Meeting US Endocrine Society1998; p 139. [Abstract P1-80].
80. Hukovic N, Panetta R, Kumar U, Rocheville M, Patel Y C. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase, and in mediating desensitization and internalization. J Biol Chem. 273:1998;21416-21422.
81. Hukovic N, Panetta R, Kumar U, Patel Y C. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): Subtype selective internalization or upregulation. Endocrinology. 137:1996;4046-4049.
82. Hunyady B, Hipkin R W, Schonbrunn A, Mezey E. Immunohistochemical localization of somatostatin receptor SSTR2A in the rat pancreas. Endocrinology. 138:1997;2632-2635.
83. Ikeda S R, Schofield G G. Somatostatin blocks a calcium current in rat sympathetic ganglion neurons. J Physiol. 409:1989;221-240.
84. James R A, Sarapura V D, Bruns C, Raulf F, Dowding J M, Gordon D F, Wood W M, Ridgway E C. Thyroid hormone induced expression of specific somatostatin receptor subtypes correlates with involution of the TtT-97 murine thyrotrope tumor. Endocrinology. 138:1997;719-724.
85. Johansson O, Hokfelt T, Elde R P. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience. 13:1984;265-339.
86. Jung B P, Nguyen T, Kolakowski L F Jr, Lynch K R, Heng H HQ, George S R, O'Dowd B F. Discovery of a novel human G protein coupled receptor gene (GPR25) located on chromosome 1. Biochem Biophys Res Commun. 230:1997;69-72.
87. Karalis K, Mastrorakos G, Chrousos G P, Tolis G. Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest. 93:1994;2000-2006.
88. Karalis K, Mastrorakos G, Sano H, Wilder R L, Chrousos G P. Somatostatin may participate in the antiinflammatory actions of glucocorticoids. Endocrinology. 136:1995;4133-4138.
89. Kaupmann K, Bruns C, Raulf F, Weber H P, Mattes H, Lubbert H. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS201-995 for the SSTR2 somatostatin receptor. EMBO J. 14:1995;727-735.
90. Khare S, Kumar U, Sasi R, Puebla L, Calderon L, Lemstrom K, Hayry P, Patel Y C. Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty. FASEB J. 13:1999;387-394.
91. Kimura N, Tomizawa S, Arai K N, Kimura N. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology. 139:1998;1573-1580.
92. Kleuss C, Heschefeler J, Ewel C, Rosenthal W, Schultz G, Wittig B. Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 353:1991;43-48.
93. Kluxen F W, Bruns C H, Lubbert H. Expression cloning of a rat brain somatostatin receptor cDNA. Proc Natl Acad Sci USA. 89:1992;4618-4622.
94. Koch B D, Schonbrunn A. Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. J Biol Chem. 263:1988;226-234.
95. Kolakowski F L, Jung B P, Nguyen T, Johnson M P, Lynch K R, Cheng R, Heng H HQ, George S R, O'Dowd B F. Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. 398:1996;253-258.
96. Komatsuzaki K, Murayama Y, Giambarella U, Ogata E, Seino S, Nishimoto I. A novel system that reports the G-proteins linked to a given receptor: A study of type 3 somatostatin receptor. FEBS Lett. 406:1997;165-170.
97. Kong H, DePaoli A M, Breder C D, Yasuda K, Bell G I, Reisine T. Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2, and SSTR3 in adult rat brain: Analysis by RNA blotting and in situ hybridization histochemistry. Neuroscience. 59:1994;175-184.
98. Kowk R PS, Lundblad J R, Chrivia J C, Richards J P, Bachinger H P, Brennan R G, Roberts S GE, Green M R, Goodman R H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226.
99. Kraus J, Woltje M, Schonwetter N, Hollt V. Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene. FEBS Lett. 428:1998;165-170.
100. Kreienkamp H J, Honck H H, Richter D. Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1). FEBS Lett. 419:1997;92-94.
101. Krempels K, Hunyady B, O'Carroll A M, Mezey E. Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract. Gastroenterology. 112:1997;1948-1960.
102. Kubota A, Yamada Y, Kagimoto S, Yasuda K, Someya Y, Ihara Y, Okamoto Y, Kozasa T, Seino S, Seino Y. Multiple effector coupling of somatostatin receptor subtype SSTR1. Biochem Biophys Res Commun. 204:1994;176-186.
103. Kumar U, Laird D, Srikant C B, Escher E, Patel Y C. Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: Quantitative analysis by double-label immunofluorescence confocal microscopy. Endocrinology. 138:1997;4473-4476.
104. Kumar, U, Ong, W-Y, Patel, S, C, Patel, Y, C, Cellular expression of the five somatostatin receptor subtypes (SSTR1-5) in rat hypothalamus: A comparative immunohistochemical analysis, Program Annual Meeting US Endocrine Society, San Diego CA June 12-15, 1999. Submitted for publication.
105. Kumar, U, Patel, S, C, Patel, Y, C, Immunohistochemical distribution of the five somatostatin receptor (SSTR) subtypes in rat cerebral cortex, Program Annual Meeting Society For Neuroscience, November 16-21, 1996.
106. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel S C, Patel Y C. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis. Diabetes. 48:1999;77-85.
107. Lamberts S WJ, Krenning E P, Reubi J-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 12:1991;450-482.
108. Lamberts S WJ, Van Der Lely A-J, de Herder W W. Drug therapy: Octreotide. N Eng J Med. 334:1996;246-254.
109. Lanneau C, Viollet C, Faivre-Bauman A, Loudes C, Kordon C, Epelbaum J, Gardette R. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: An electrophysiological and single cell RT-PCR study. Eur J Neurosci. 10:1998;204-212.
110. Larsson L I, Golterman N, De Magistris L, Rehfeld J F, Schwartz T W. Somatostatin cell processes as pathways for paracrine secretion. Science. 205:1979;1393-1395.
111. Le Romancer M, Cherifi Y, Levasseur S, Laigneau J P, Peranzi G, Jois P, Lewin M J, Reyl-Desmars F. Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae. Life Sci. 58:1996;1091-1098.
112. Li X-J, Forte M, North R A, Ross C A, Snyder S H. Cloning and expression of a rat somatostatin receptor enriched in brain. J Biol Chem. 267:1992;21307-21312.
113. Liapakis G, Haeger C, Rivier J, Reisine T. Development of a selective agonist at the somatostatin receptor subtype SSTR1. JPET. 276:1996;1089-1094.
114. Liebow C, Reilly C, Serrano M. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA. 86:1989;2003-2007.
115. 1 pituitary cells. J Biol Chem. 269:1994;13880-13886.
116. Lloyd K C, Amirmoazzami S, Friedik F, Chew P, Walsh J H. Somatostatin inhibits gastrin release and acid secretion by activating sst2 in dogs. Am J Physiol. 272:1997;G1481-G1488.
117. Lopez F, Esteve J P, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signalling. J Biol Chem. 272:1997;24448-22454.
118. Loumaye E, Catt K J. Agonist-induced regulation of pituitary receptors for gonadotrophin releasing hormone. J Biol Chem. 258:1983;12002-12009.
119. Luini A, de Matteis M A. Evidence that receptor-linked G protein inhibits exocytosis by a post-second messenger mechanism in AtT-20 cells. J Neurochem. 54:1990;30-38.
120. Luthin D R, Eppler C M, Linden J. Identification and quantification of Gi-type GTP-binding proteins that copurify with a pituitary somatostatin receptor. J Biol Chem. 268:1993;5990-5996.
121. 2 adrenergic receptor-Src protein kinase complexes. Science. 283:1999;655-660.
122. Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R. Selective effects of somatostatin-14, -25, and -28 on in vitro insulin and glucagon secretion. Nature. 291:1981;76-77.
123. 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate. Proc Natl Acad Sci USA. 88:1991;9016-9020.
124. Martinez V, Curi A P, Torkian B, Schaeffer J M, Wilkinson H A, Walsh J H, Tache Y. High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology. 114:1998;1125-1132.
125. McDonald J K, Greiner F, Bauer G E, Elde R P, Noe B D. Separate cell types that express two different forms of somatostatin in anglerfish islets can be immunohistochemically differentiated. J Histochem Cytochem. 35:1987;155-162.
126. 2+ current modulated by cGMP-dependent protein kinase. Nature. 369:1994;336-339.
127. Meyerhof W, Wulfsen I, Schonrock C, Fehr S, Richter D. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain. Proc Natl Acad Sci USA. 89:1992;10267-10271.
128. Mezey E, Hunyady B, Mitra S, Hayes E, Liu Q, Schaeffer J, Schonbrunn A. Cell specific expression of the SSTR2A and SSTR5 somatostatin receptors in the rat anterior pituitary. Endocrinology. 139:1998;414-419.
129. Montminy M, Brindle P, Arias J, Ferreri K, Armstrong R. Regulation of somatostatin gene transcription by cAMP. Somatostatin and Its Receptors Ciba Foundation Symposium 190, West Sussex, UK. 1995;Wiley. p. 7-20.
130. Montminy M R, Goodman R H, Horovitch S J, Habener J F. Primary structure of the gene encoding rat preprosomatostatin. Proc Natl Acad Sci USA. 81:1984;3337-3340.
131. Montminy M R, Low M J, Tapia-Arancibia L, Reichlin S, Mandel G, Goodman R H. Cyclic AMP regulates somatostatin mRNA accumulation in primary diencephalic cultures and in transfected fibroblast cells. J Neurosci. 6:1985;1171-1176.
132. Morel G, Leroux P, Pelletier G. Ultrastructural autoradiographic localization of somatostatin-28 in the rat pituitary gland. Endocrinology. 116:1985;1615-1620.
133. Murthy K S, Coy D H, Makhlouf G. Somatostatin receptor-mediated signalling in smooth muscle. J Biol Chem. 271:1996;23458-23463.
134. Neel B. Structure and function of SH2-domain containing tyrosine phosphate. Semin Cell Biol. 4:1993;419-432.
135. Nehring R B, Meyerhof W, Richter D. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol. 14:1995;939-944.
136. 2L receptor to desensitization accompanies the upregulation of receptors onto the surface of Sf9 cells. Endocrinology. 138:1997;4199-4206.
137. Nouel D, Gaudriault G, Houle M, Reisine T, Vincent J-P, Mazella J, Beaudet A. Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: A confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology. 138:1997;296-306.
138. O'Carroll A M, Krempel K. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology. 136:1995;5224-5227.
139. O'Carroll A M, Lolait S J, Konig M, Mahan L C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol. 42:1992;939-946.
140. Pagliacci M C, Tognellinin R, Grignani F, Nicoletti F. Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS201-995: Effects on cell cycle parameters and apoptotic cell death. Endocrinology. 129:1991;2555-2562.
141. Pan M G, Florio T, Stork P JS. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science. 256:1992;1215-1217.
142. Panetta R, Greenwood M T, Warszynska A, Demchyshyn L L, Day R, Niznik H B, Srikant C B, Patel Y C. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol Pharmacol. 45:1994;417-427.
143. Panetta R, Patel Y C. Expression of mRNA for all 5 human somatostatin receptor (hSSTR1-5) in pituitary tumors. Life Sci. 56:1994;333-342.
144. Patel P C, Barrie R, Hill N, Landeck S, Kurozawa D, Woltering E A. Post receptor signal transduction mechanisms involved in octreotide induced inhibition of angiogenesis. Surgery. 116:1994;1148-1152.
145. Patel Y C. General aspects of the biology and function of somatostatin. Weil C, Muller E E, Thorner M O. Basic and Clinical Aspects of Neuroscience. 1992;1-16 Springer-Verlag, Berlin.
146. Patel Y C. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest. 20:1997;348-367.
147. Patel Y C, Greenwood M T, Kent G, Panetta R, Srikant C B. Multiple gene transcripts of the somatostatin receptor SSTR2: Tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun. 192:1993;288-294.
148. Patel Y C, Greenwood M T, Panetta R, Demchyshyn L, Niznik H, Srikant C B. The somatostatin receptor family: A mini review. Life Sci. 57:1995;1249-1265.
149. Patel Y C, Greenwood M T, Warszynska A, Panetta R, Srikant C B. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun. 198:1994;605-612.
150. Patel Y C, Liu J L, Galanopoulou A S, Papachristou D N. Production, action, and degradation of somatostatin. Jefferson L S, Cherrington A D. The Handbook of Physiology, The Endocrine Pancreas and Regulation of Metabolism. 1999;Oxford Univ. Press, New York:
151. Patel Y C, Murthy K K, Escher E, Banville D, Spiess J, Srikant C B. Mechanism of action of somatostatin: An overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism. 39:1990;63-69.
152. Patel Y C, Panetta R, Escher E, Greenwood M, Srikant C B. Expression of multiple somatostatin receptor genes in AtT-20 cells: Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem. 269:1994;1506-1509.
153. 2. Endocrinology. 128:1991;1754-1762.
154. Patel Y C, Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain and peripheral tissues of the rat. Endocrinology. 102:1978;523-530.
155. Patel Y C, Srikant C B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr1-5). Endocrinology. 135:1994;2814-2817.
156. Patel Y C, Srikant C B. Somatostatin receptors. Trends Endocrinol Metab. 8:1997;398-405.
157. Pradayrol L, Jornvall H, Mutt V, Ribet A. N-terminally extended somatostatin: The primary structure of somatostatin 28. FEBS Lett. 109:1980;55-58.
158. Presky D H, Schonbrunn A. Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J Biol Chem. 263:1988;714-721.
159. Pscherer A, Dorflinger U, Kirfel J, Gawlas K, Ruschoff J, Buettner R, Schule R. The helix-loop-helix transcription factor SEF2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J. 15:1996;6680-6690.
160. Puebla, L, Khare, S, Sasi, R, Bennett, H, JP, James, S, Mouchantaf, R, Patel, Y, C, Processing of rat preprocortistatin in mouse AtT-20 cells. Submitted for publication.
161. Quintela M, Senaris R M, Dieguez C. Transforming growth factor-βs inhibit somatostatin messenger ribonucleic acid levels and somatostatin secretion in hypothalamic cells in culture. Endocrinology. 138:1997;4401-4409.
162. Quintela M, Senaris R, Heiman M L, Casanueva F F, Dieguez C. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology. 138:1997;5641-5644.
163. Rauly I, Saint-Laurent N, Delesque N, Buscail L, Esteve J-P, Vaysse N, Susini C. Induction of a negative autocrine loop by expression of Sst2 somatostatin receptor in NIH 3T3 cells. J Clin Invest. 97:1996;1874-1883.
164. Reardon D B, Dent P, Wood S L, Kong T, Sturgill T W. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: Coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol Endocrinol. 11:1997;1062-1069.
165. Reardon D B, Wood S L, Brautigan D L, Bell G I, Dent P, Sturgill T W. Activation of a protein tyrosine phosphate and inactivation of Raf-1 by somatostatin. Biochem J. 31:1996;401-404.
166. Reichlin S. Somatostatin. N Engl J Med. 309:1983;1495-1501.
167. Reisine T D, Axelrod J. Prolonged somatostatin treatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase. Endocrinology. 113:1983;811-813.
168. Reisine T, Bell G I. Molecular biology of somatostatin receptors. Endocr Rev. 16:1995;427-442.
169. Renstrom E, Ding W G, Bokvist K, Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting β cells by activation of calcineurin. Neuron. 17:1996;513-522.
170. Reubi J C, Horisberger U, Kappeler A, Laissue J A. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood. 92:1998;191-197.
171. Reubi J C, Waser B, Lamberts S WJ, Mengod G. Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: Comparison with SRIH receptor content. J Clin Endocrinol Metab. 76:1993;642-647.
172. Rocheville, M, Hukovic, N, Patel, Y, C. Functional dimerization of the human somatostatin receptor subtype 5 (hSSTR5). Program Annual Meeting US Endocrine Society, New Orleans, 1998; 115. [Abstract OR46-6].
173. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R. Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci USA. 90:1993;4196-4200.
174. Rohrer S P, Birzin E T, Mosley R T, Berk S C, Hutchins S M, Shen D-M, Xiong Y, Hayes E C, Parmar R M, Foor F, Mitra S W, Degrado S J, Shu M, Klopp J M, Cai S J, Blake A, Chan W WS, Pasternak A, Yang L, Patchett A A, Smith R G, Chapman K T, Schaeffer J M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science. 282:1998;737-740.
175. 2+ currents in rat insulinoma 1046-38 cells. FEBS Lett. 425:1998;137-140.
176. Roth A, Kreienkamp H J, Meyerhof W. Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization. J Biol Chem. 38:1997;23769-23774.
177. Roth A, Kreienkamp H J, Nehring R B, Roosterman D, Meyerhof W, Richter D. Endocytosis of the rat somatostatin receptors - Subtype discrimination, ligand specificity and delineation of carboxyterminal positive and negative sequence motifs. DNA Cell Biol. 16:1997;111-119.
178. Sasi R, Puebla L, Khare S, Patel Y C. Polymorphism in the 5′ flanking region of the human somatostatin receptor subtype 5 (hSSTR5). Gene. 214:1998;45-49.
179. Scarborough D E, Lee S L, Dinarello C A, Reichlin S. Interleukin-1β stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology. 124:1989;549-551.
180. Schonbrunn A, Tashjian A H Jr. Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem. 253:1978;6473-6483.
181. Schwartz T W, Rosenkilde M M. Is there a lock for all agonist keys in 7 TM receptors. TIPS. 17:1996;213-216.
182. Schweitzer R, Madamba S, Siggins G R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature. 346:1990;464-466.
183. Senogles S E. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J Biol Chem. 269:1994;23120-23127.
184. Sharma K, Patel Y C, Srikant C B. Subtype selective induction of p53-dependent apoptosis but not cell cycle arrest by human somatostatin receptor 3. Mol Endocrinol. 10:1996;1688-1696.
185. Sharma K, Srikant C B. G protein coupled receptor signaled apoptosis is associated with activation of a cation insensitive acidic endonuclease and intracellular acidification. Biochem Biophys Res Commun. 242:1998;134-140.
186. Sharma K, Srikant C B. Induction of wild type p53, bax and acidic endonuclease during somatostatin signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer. 76:1998;259-266.
187. Sharma K, Patel Y C, Srikant C B. C-terminal region of human somatostatin receptor 5 is required for induction of Rb and Gi cell cycle arrest. Mol Endocrinol. 13:1999;82-90.
188. Shen L P, Rutter W J. Sequence of the human somatostatin I gene. Science. 224:1984;168-171.
189. Shimon I, Taylor J E, Dong J Z, Bitonte R A, Kim S, Morgan B, Coy D H, Culler M D, Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary culture. J Clin Invest. 99:1997;789-798.
190. + conductance in freshly dispersed rat somatotrophs. J Physiol. 441:1991;615-637.
191. Srikant C B. Cell cycle dependent induction of apoptosis by somatostatin analog SMS201-995 in AtT-20 mouse pituitary tumor cells. Biochem Biophys Res Commun. 209:1995;400-407.
192. Srikant C B, Murthy K K, Escher E, Patel Y C. Photoaffinity labelling of the somatostatin receptor: Identification of molecular subtypes. Endocrinology. 130:1992;2937-2946.
193. Srikant C B, Patel Y C. Receptor binding of somatostatin-28 is tissue specific. Nature. 294:1981;259-260.
194. Srikant C B, Shen S H. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast cancer adenocarcinoma cells. Endocrinology. 137:1996;3461-3468.
195. Strader C D, Fong T M, Graziano M P, Tota M R. The family of G protein coupled receptors. FASEB J. 9:1995;745-754.
196. Sullivan S J, Schonbrunn A. Distribution of somatostatin receptors in RINm5F insulinoma cells. Endocrinology. 122:1988;1137-1145.
197. + current in human growth hormone-secreting adenoma cells. Endocrinology. 138:1997;2405-2409.
198. Takeba Y, Suzuki N, Takeno M, Asai T, Tsuboi S, Hoshino T, Sakane T. Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis. Arthritis Rheumatism. 40:1997;2128-2138.
199. Tallent M, Reisine T. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells. Mol Pharmacol. 41:1992;452-455.
200. Tannenbaum G S, Zhang W-H, Lapointe M, Zeitler P, Beaudet A. Growth hormone-releasing hormone neurons in the arcuate nucleus express both Sst1 and Sst2 somatostatin receptor genes. Endocrinology. 139:1998;1450-1453.
201. Taylor J E, Coy D H. The receptor pharmacology of somatostatin agonists and antagonists: Implications for clinical utility. J Endocrinol Invest. 20:1997;8-10.
202. Thomas R F, Holt B D, Schwinn D A, Liggett S B. Longterm agonist exposure induces upregulation of β3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA. 89:1992;4490-4494.
203. Thoss V S, Perez J, Duc D, Hoyer D. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology. 34:1995;1673-1688.
204. Thoss V S, Perez J, Probat A, Hoyer D. Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Arch Pharmacol. 354:1996;411-419.
205. Tolon R M, Sanchez F F, de los Frailes M T, Lorenzo M J, Cacicedo L. Effect of potassium-induced depolarization on somatostatin gene expression in cultured fetal rat cerebrocortical cells. J Neurosci. 14:1994;1053-1059.
206. Tostivini H, Likrmann I, Bucharles C, Vieau D, Coulouarn Y, Fournier A, Conlon J M, Vaudry H. Occurrence of two somatostatin variants in the frog brain: Characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides. Proc Natl Acad Sci USA. 93:1996;12605-12610.
207. Tran V T, Beal M F, Martin J B. Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science. 228:1985;492-495.
208. Tsuzaki S, Moses A C. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor I in FRTL5 cells. Endocrinology. 126:1990;3131-3138.
209. Vanetti M, Kouba M, Wang X, Vogt G, Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311:1992;290-294.
210. Veber D, Saperstein R, Nutt R, Friedinger R, Brady S, Curley P, Perlow D, Palveda W, Colton C, Zacchei A, Tocco D, Hoff D, Vandlen R, Gerich J, Hall L, Mandarino L, Cordes E, Anderson P, Hirschmann R. A superactive cyclic hexapeptide analog of somatostatin. Life Sci. 34:1984;1371-1378.
211. Viana F, Hille B. Modulation of high voltage-activated calcium channels by somatostatin in acutely isolated rat amygdaloid neurons. J Neurosci. 16:1996;6000-6011.
212. Vidal C, Rauly I, Zeggari M, Delesque N, Esteve J P, Saint-Laurent N, Vaysse N, Susini C. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol. 46:1994;97-104.
213. Viguerie N, Tahiri-Jouti N, Ayral A M, Cambillau C, Scemama J L, Bastie M J, Knuhtsen S, Esteve J P, Pradayrol L, Susini C, Vaysse N. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology. 124:1989;1017-1025.
214. Visser-Wisselaar H A, Van Uffelen C JC, Van Koetsveld P M, Lichtenauer-Kaligis E GR, Waaijers A M, Uitterlinden P, Movy D M, Lamberts S WJ, Hofland L J. 17 estradiol dependent regulation of somatostatin receptor subtype expression in the 7315 b prolactin secreting rat pituitary tumor in vitro and in vivo. Endocrinology. 138:1997;1180-1189.
215. Wang H L, Bogen C, Reisine T, Dichter M. Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc Natl Acad Sci USA. 86:1989;9616-9620.
216. Weckbecker G, Raulf F, Stolz B, Bruns C. Somatostatin analogs for diagnosis and treatment of cancer. Pharmac Ther. 60:1993;245-264.
217. Weckbecker G, Tolcsvai L, Stolz B, Pollack M, Bruns C. Somatostatin analogue octreotide enhances the antineoplastic effect of tamoxifen and ovariectomy on 7, 12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res. 54:1994;6334-6337.
218. Weiss R E, Reddi A H, Nimni M E. Somatostatin can locally inhibit proliferation and differentiation of cartilage and bone precursor cells. Calcif Tissue Int. 33:1981;425-430.
219. + channels through protein dephosphorylation. Nature. 351:1991;570-573.
220. Wilkinson G F, Feniuk W, Humphrey P PA. Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoionositide metabolism. Br J Pharmacol. 121:1997;91-96.
221. Wollheim C B, Winiger B P, Ullrich S. Somatostatin inhibition of hormone release: Effects on cytosolic Cal′ and interference with distal secretory events. Metabolism. 39:1990;101-104.
222. 1 cells. Endocrinology. 136:1995;5070-5075.
223. Xu Y, Berelowitz M, Bruno J F. Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness. Mol Cell Endocrinol. 139:1998;71-77.
224. Xu Y, Bruno J F, Berelowitz M. Characterization of the proximal region of the rat somatostatin receptor gene, SSTR4. Biochem Biophys Res Commun. 206:1995;935-941.
225. Xu Y, Song J, Berelowitz M, Bruno J F. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology. 137:1996;5634-5640.
226. Yamada Y, Post S R, Wang K, Tager H S, Bell G I, Sein S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA. 89:1992;251-255.
227. Yamada Y, Reisine T, Law S F, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell G I, Seino S. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylate cyclase. Mol Endocrinol. 6:1993;2136-2142.
228. Yang L, Berk S C, Rohrer S P, Mosley R T, Guo L, Underwood D J, Arison B H, Birzin E T, Hayes E C, Mitra S W, Parmar R M, Cheng K, Wu T J, Butler B S, Foor F, Pasternak A, Pan Y, Silva M, Freidinger R M, Smith R G, Chapman K, Schaeffer J M, Patchett A A. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA. 95:1998;10836-10841.
229. Yasuda K, Rens-Domiano S, Breder C D, Law S F, Saper C B, Reisine T, Bell G I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J Biol Chem. 267:1992;20422-20428.
230. Yoshitomi H, Fujii Y, Miyazaki M, Nakajima M, Inagaki N, Seino S. Involvement of MAP kinase and cfos signalling in the inhibition of cell growth by somatostatin. Am J Physiol Endocrinol Metab. 35:1997;E769-E774.
231. Zeggari M, Esteve J P, Rauly I, Cambillau C, Mazarguil H, Dufresne M, Pradayrol L, Chayvialle J A, Vaaysse N, Susini C. Copurification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem J. 303:1994;441-448.
232. Zheng H, Bailey A, Jiang M H. Somatostatin receptor subtype 2 knock out mice are refractory to growth hormone, negative feedback on arcuate neurons. Mol Endocrinol. 11:1997;1709-1717.
233. Zhu L J, Krempels K, Bardin C W, O'Carroll A M, Mezey E. The localization of messenger ribonucleic acids for somatostatin receptors 1, 2, and 3 in rat testes. Endocrinology. 139:1998;350-357.